{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:37:20Z","timestamp":1787906240598,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Sickle cell disease (SCD) is a group of inherited haematological disorders, which affects the shape of the oxygen-carrying haemoglobin component of erythrocytes, giving it an abnormal sickle-shaped appearance. This disease is one of the most common haematological disorders in Nigeria and is generally characterized by anaemia, painful crises, and multi-organ dysfunction. Recurrent episodes of painful crises account for most of the morbidities and mortalities observed in SCD, particularly sickle cell anaemia. This has been a critical concern in the field of haematology and molecular genetics as several therapeutic solutions have been explored over the past few years to treat symptoms of this disease and alleviate painful crises. However, most of these treatment options are not readily available and affordable to affected patients in lower socioeconomic settings in Nigeria, causing a wider range of complications and end-stage organ failure. To address this issue, this article explores an overview of SCD, management alternatives and the need for newer therapeutic solutions to cover the gaps or inadequacies of effective sickle cell crisis management.<\/jats:p>","DOI":"10.1097\/ms9.0000000000000696","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T07:10:22Z","timestamp":1709277022000},"page":"2282-2286","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Tackling sickle cell crisis in Nigeria: the need for newer therapeutic solutions in sickle cell crisis management \u2013 short communication"],"prefix":"10.1097","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8624-3067","authenticated-orcid":false,"given":"Ekene","family":"Mary Nnagha","sequence":"first","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"College of Medical Sciences, University of Calabar, Calabar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0502-7520","authenticated-orcid":false,"given":"Matthew","family":"Kayode Ademola","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"Obafemi Awolowo University Teaching Hospital, Ile-Ife"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eghosa","family":"Ann Izevbizua","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"Benjamin S. Carson College of Health and Medical Sciences, Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0692-9027","authenticated-orcid":false,"given":"Olivier","family":"Uwishema","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"Clinton Global Initiative University, New York, New York, USA"},{"name":"Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6650-6982","authenticated-orcid":false,"given":"Abubakar","family":"Nazir","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"Department of Medicine, King Edward Medical University, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5511-1491","authenticated-orcid":false,"given":"Jack","family":"Wellington","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"Faculty of Medicine, Cardiff University School of Medicine, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5]]},"reference":[{"issue":"Suppl 1","key":"R1-20250806","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/ijlh.13023","article-title":"Sickle cell disease: reducing the global disease burden","volume":"41","author":"Mburu","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s11739-019-02160-x","article-title":"Sickle cell disease; a review for the internist","volume":"14","author":"Pinto","year":"2019","journal-title":"Intern Emerg Med"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/mi12050519","article-title":"Techniques for the detection of sickle cell disease: a review","volume":"12","author":"Arishi","year":"2021","journal-title":"Micromachines (Basel)"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/ijlh.12082","article-title":"Red blood cell morphology","volume":"35","author":"Ford","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.htct.2020.11.010","article-title":"HemoTypeSC point-of-care testing shows high sensitivity with alkaline cellulose acetate hemoglobin electrophoresis for screening hemoglobin SS and SC genotypes","volume":"44","author":"Adegoke","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/ijns4040039","article-title":"Newborn screening for sickle cell disease and other hemoglobinopathies: a short review on classical laboratory methods-isoelectric focusing, HPLC, and capillary electrophoresis","volume":"4","author":"Fr\u00f6mmel","year":"2018","journal-title":"Int J Neonatal Screen"},{"key":"R7-20250806","first-page":"257805","article-title":"Detection of abnormal hemoglobin variants by HPLC method: common problems with suggested solutions","volume":"2014","author":"Pant","year":"2014","journal-title":"Int Sch Res Notices"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1039\/c3lc41302k","article-title":"A simple, rapid, low-cost diagnostic test for sickle cell disease","volume":"13","author":"Yang","year":"2013","journal-title":"Lab Chip"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bcmd.2019.01.007","article-title":"HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: promises and challenges","volume":"78","author":"Nnodu","year":"2019","journal-title":"Blood Cells Mol Dis"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ajcp\/aqz108","article-title":"Multicenter evaluation of HemoTypeSC as a point-of-care sickle cell disease rapid diagnostic test for newborns and adults across India","volume":"153","author":"Mukherjee","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12916-015-0473-6","article-title":"Validation of a novel point of care testing device for sickle cell disease","volume":"13","author":"Kanter","year":"2015","journal-title":"BMC Med"},{"key":"R12-20250806","first-page":"87","article-title":"Sickle cell disease in Nigeria \u2013 a preview","volume":"16","author":"Emechebe","year":"2017","journal-title":"J Dent Med Sci"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of 2014 evidence based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4314\/ahs.v21i2.36","article-title":"Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria","volume":"21","author":"Ofakunrin","year":"2021","journal-title":"Afr Health Sci"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.4081\/hr.2018.7419","article-title":"GBT440 reverses sickling of sickled red blood cells under hypoxic conditions in vitro","volume":"10","author":"Dufu","year":"2018","journal-title":"Hematol Rep"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood.V124.21.1370.1370","article-title":"GTx011, an anti-sickling compound, improves SS blood rheology by reduction of HbS polymerization via allosteric modulation of O2 affinity","volume":"124","author":"Patel","year":"2014","journal-title":"Blood"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"R18-20250806","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/inthealth\/iht022","article-title":"Current sickle cell disease management practices in Nigeria","volume":"6","author":"Galadanci","year":"2013","journal-title":"Int Health"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4314\/mmj.v34i2.9","article-title":"Folate levels in children with sickle cell anaemia on folic acid supplementation in steady state and crises at a tertiary hospital in Enugu, Nigeria: a prospective, comparative study","volume":"34","author":"Nnajekwu","year":"2022","journal-title":"Malawi Med J"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N Engl J Med"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1182\/blood.V124.21.86.86","article-title":"A phase 3 study of L-glutamine therapy for sickle cell anemia and sickle b0-thalassemia","volume":"124","author":"Niihara","year":"2014","journal-title":"Blood"},{"key":"R22-20250806","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/17474086.2022.2031967","article-title":"Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis","volume":"15","author":"Shah","year":"2022","journal-title":"Expert Rev Hematol"},{"key":"R23-20250806","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood-2018-03-834440","article-title":"l-Glutamine for sickle cell anemia: more questions than answers","volume":"132","author":"Quinn","year":"2018","journal-title":"Blood"},{"key":"R24-20250806","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"key":"R25-20250806","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.seminhematol.2018.04.014","article-title":"Genetic therapies for sickle cell disease","volume":"55","author":"Esrick","year":"2018","journal-title":"Semin Hematol"},{"key":"R26-20250806","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-med-041817-125507","article-title":"Emerging genetic therapy for sickle cell disease","volume":"70","author":"Orkin","year":"2019","journal-title":"Annu Rev Med"},{"key":"R27-20250806","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/17474086.2018.1486703","article-title":"Stem cell transplantation in sickle cell disease: therapeutic potential and challenges faced","volume":"11","author":"Leonard","year":"2018","journal-title":"Expert Rev Hematol"},{"key":"R28-20250806","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","article-title":"Hematopoietic stem cell gene therapy: progress and lessons learned","volume":"21","author":"Morgan","year":"2017","journal-title":"Cell Stem Cell"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:32:43Z","timestamp":1754487163000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000000696","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"assertion":[{"value":"2023-02-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}